Fusion Pharmaceuticals Inc (FUSN)
21.50
+0.08
(+0.40%)
USD |
NASDAQ |
May 02, 09:59
Fusion Pharmaceuticals Total Liabilities (Quarterly): 63.36M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 63.36M |
| September 30, 2023 | 64.91M |
| June 30, 2023 | 65.32M |
| March 31, 2023 | 65.72M |
| December 31, 2022 | 56.84M |
| September 30, 2022 | 55.35M |
| June 30, 2022 | 29.23M |
| March 31, 2022 | 20.53M |
| December 31, 2021 | 20.82M |
| Date | Value |
|---|---|
| September 30, 2021 | 21.81M |
| June 30, 2021 | 18.60M |
| March 31, 2021 | 18.24M |
| December 31, 2020 | 16.16M |
| September 30, 2020 | 5.605M |
| June 30, 2020 | 7.903M |
| March 31, 2020 | 15.05M |
| December 31, 2019 | 102.89M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.605M
Minimum
Sep 2020
102.89M
Maximum
Dec 2019
38.14M
Average
21.81M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| AstraZeneca PLC | 64.79B |
| Landos Biopharma Inc | 6.249M |
| Acasti Pharma Inc | 11.50M |
| Aurinia Pharmaceuticals Inc | 170.11M |
| Edesa Biotech Inc | 1.987M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 285.84M |
| Shareholders Equity (Quarterly) | 222.48M |